AFFO Guidance Raised
Omega Healthcare raised and narrowed its 2025 AFFO guidance to a range of $3.04 to $3.07 per share, reflecting strong earnings and strategic financial decisions.
Strong Revenue Growth
Second quarter 2025 revenue was $283 million, a 11.86% increase from $253 million in the second quarter of 2024, driven by new investments and operator restructurings.
Solid Balance Sheet and Leverage
The company's balance sheet is strong with adjusted annualized EBITDA of nearly $1.2 billion and net funded debt of only $4.3 billion, and a leverage ratio of 3.67x, the lowest in over a decade.
Significant New Investments
Completed over $605 million in new investments in 2025, with a focus on real estate acquisitions, including a $344 million investment in the U.K.
Genesis Bankruptcy Support
Omega is committed to supporting Genesis through its Chapter 11 bankruptcy with $8 million in debtor-in-possession financing, expecting full rent payments during the process.
Maplewood Performance
Maplewood paid $17.6 million in rent in the second quarter, with a strong occupancy level of 95%, indicating robust portfolio performance.